Subcutaneous ICDsTake Care of Lead Problems in ATLAS Trial
SAN FRANCISCO — Candidates for an implantable cardioverter-defibrillator (ICD) discovered {that a} subcutaneous machine dramatically slashed the key lead-related problems seen with transvenous units, although traits steered worse ICD efficiency with out assembly statistical significance. Within the ATLAS trial of greater than 500 sufferers, main lead-related problems occurred in 0.4% of those that had a … Read more